Real-world management and long-term outcomes of diabetic macular oedema with good visual acuity.

DMO with good initial visual acuity should be monitored closely, as delay in treatment initiation is associated with worse visual outcomes. BCVA at time of initial treatment is the strongest determinant of final visual acuity.